Form 4: Amphastar Pharmaceuticals Director Floyd F. Petersen Sells Shares Under 10b5-1 Plan

Director Floyd F. Petersen sold 500 shares of Amphastar Pharmaceuticals (AMPH) at a weighted average price of $43.4283 on April 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On April 1, 2024, Floyd F. Petersen, a director of Amphastar Pharmaceuticals, sold 500 shares of common stock.
• The sale was executed at a weighted average price of $43.4283 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on June 13, 2023.
• Following the transaction, Petersen directly owns 79,333 shares of Amphastar Pharmaceuticals.
• The shares were sold in multiple transactions at prices ranging from $43.145 to $43.97.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Sales by insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan suggests the insider is selling shares in a pre-planned manner to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale relative to the director's holdings.

Key Dates